Login / Signup

Mesothelin as a target for cervical cancer therapy.

Korinna JöhrensLea LazzeriniJana BarinoffJalid SehouliGuenter Cichon
Published in: Archives of gynecology and obstetrics (2018)
Mesothelin should be taken into account as a target in cervical cancer therapy and histological determination of Mesothelin expression should be considered in routine diagnostics of cervical carcinomas.
Keyphrases
  • cancer therapy
  • drug delivery
  • poor prognosis
  • high grade
  • long non coding rna
  • mass spectrometry